Back to Top Skip to main content Skip to sub-navigation

Military Health System participating in COVID-19 vaccine trial

Woman measuring out a vaccine into a needle Five military medical treatment facilities are participating in a Phase 3 clinical trial testing a COVID-19 vaccine in development with AstraZeneca. (Photo by Air Force Staff Sgt. Joshua Garcia.)

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Vaccine Trials

Five military medical treatment facilities in the National Capital Region, Texas, and California are participating in a phase 3 clinical trial testing the AstraZeneca COVID-19 vaccine in development under Operation Warp Speed.  The DoD sites are actively enrolling study participants, with a goal to recruit up to 1,000 volunteers in each of the three market areas towards the total AstraZeneca clinical trial enrollment of 30,000 people.

Operation Warp Speed, a multiagency U.S. Government effort led by the Department of Health and Human Services and the Department of Defense, is working with the private sector with the aims to deliver safe and effective COVID-19 vaccine doses to the American public beginning January 2021.

OWS is funding clinical trials evaluating several vaccine candidates which were selected based on promising data on safety, immune response, and protection in animal studies and safety and immune response data in early-stage trials in humans. Each of the trials is designed to collect data on how well a vaccine candidate protects against COVID-19 and on the safety of the vaccine candidate in a larger population, including people most at risk.  

“The Department of Defense continues to play a key role in the development of a potential COVID-19 vaccine,” said Thomas McCaffery, assistant secretary of Defense for Health Affairs. “Now that vaccines have passed the first phases of testing for safety, dosing, and response, we have moved into the next phase where volunteers are needed to join large clinical studies. We are excited to have several sites supporting these next steps in the vaccine development process.”

Large phase 3 clinical trials are a necessary part of the rigorous scientific process to test the efficacy and safety of a vaccine in a real-world setting with a large population sample, said Air Force Col (Dr.) Jessica Cowden, chief medical officer of the DoD Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Enabling Biotechnology Vaccine Acceleration Project.

“Phase 3 studies are designed to evaluate if the vaccine can prevent disease in the populations of people that the vaccine is being developed to protect,” said Cowden. “Phase 3 studies are large and usually involve some people who are at risk for infection and disease.”

The National Institute of Allergy and Infectious Diseases at the National Institutes of Health established a network of infectious disease experts and research partners, termed the Coronavirus Prevention Network, or CoVPN, to rapidly and thoroughly evaluate U.S. government-sponsored COVID-19 vaccines. The CoVPN website (https://www.coronaviruspreventionnetwork.org/) provides general information about products being developed to prevent COVID-19 and about clinical trials.

According to the CoVPN, interested volunteers must be adults aged 18 and older to be screened for these initial trials. The CoVPN recognizes the importance of including volunteers who are more likely to get COVID-19, such as those over the age of 65 or with underlying medical conditions; as well as people who work in an essential job, live in a densely populated area, or represent a racial and ethnic group greatly impacted by the epidemic.

Representation by such groups matters in Phase 3 trials because vaccines need to be tested in populations who are at most risk of being exposed to the disease and getting sick in the real world, explained Cowden. “At-risk populations shouldn’t bear a disproportionate burden of research, but they need to be represented,” she said

The selected DoD sites are currently enrolling volunteers for the AstraZeneca clinical trial, according to Cowden. The trial is a randomized control, double-blind study, meaning volunteers will either receive the study vaccine or saline. “The study team and the participant will be blinded so that they won’t know which the participant received until the end of the study,” Cowden said. AstraZeneca’s vaccine candidate is in late-stage clinical trials ongoing in the U.K., Brazil and South Africa.

“Participating in a vaccine clinical trial is voluntary but is also critically vital to ensure that the overall effort is ultimately successful,” said Dr. Sean Biggerstaff, acting deputy director, DHA Research and Development Directorate. “Volunteers should also know safety remains an overriding priority for anyone participating in clinical trials.”

Military health beneficiaries who wish to volunteer for the AstraZeneca COVID-19 vaccine at a nearby military medical treatment facility (or at a civilian site close to home) can contact the local study team directly to request more information or can register on the CoVPN website and consent to be contacted by a research team. If registering on the CoVPN site, interested volunteers should enter the appropriate code in parenthesis from the list below, or enter their ZIP code to join the registry. Site contact information is included here:

At this point, the DoD is only participating in the AstraZeneca study. Additional DoD sites are being prepared for participation in other clinical trials of vaccines and monoclonal antibodies to prevent COVID-19, said Cowden.

“Having a safe and effective COVID-19 vaccine is what we need to protect people and get life back to normal, but in order to get to that point, we have to do these clinical trials,” explained Cowden. “These big Phase 3 clinical trials with a lot of people participating are critical so we can get the information we need to determine if a vaccine candidate is safe and can prevent COVID-19.”

You also may be interested in...

Secretary of Defense Video to the Force on COVID-19 Vaccinations

Video
2/24/2021
Image of soldier looking through COVID vaccine information laid out on a table

The Secretary of Defense addressed the entire workforce to encourage informed decision-making with regards to coronavirus-19 vaccination.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

DOD participates in new COVID-19 antibody combination prevention trial

Article
2/23/2021
Woman gets blood drawn

Five DoD sites across the United States will be part of the STORM CHASER trial, a study to observe the efficacy of a long-lasting antibody product to prevent COVID-19 among people who have been exposed to others suffering from the disease.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Trained military personnel ready to help with COVID-19 vaccinations

Article
2/23/2021
Military health personnel wearing a mask giving the COVID-19 vaccine to a man who is also wearing a face mask

Military prepped and ready to help with civilian COVID-19 mass vaccinations

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | Immunizations

Marines, Sailors with PHIBRON 11, 31st MEU receive COVID-19 vaccine

Article
2/19/2021
Military health personnel giving the COVID-19 Vaccine to military personnel

Vaccination for service members is voluntary, as vaccines are currently authorized for emergency use.

Recommended Content:

Coronavirus | Immunization Healthcare | COVID-19 Vaccine Efforts

USU cohort study investigates COVID-19 impacts on DOD personnel

Article
2/18/2021
Military health personnel wearing a mask and a face shield holding up a sign that has the number eighteen on it

USU is conducting a study to better understand the symptoms and course of COVID-19 disease and identify risk factors in the military population.

Recommended Content:

Immunizations | COVID-19 Vaccine Efforts | Coronavirus

COVID-19, Influenza provide twice the challenge to healthcare workers

Article
2/17/2021
Military personnel wearing a face mask while holding hand sanitizer

The ongoing pandemic outbreak has overlapped with the annual Northern Hemisphere influenza season.

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

COVID-19 vaccine does not affect fertility, immunization experts say

Article
2/16/2021
Black and white photo of a couple holding hands

COVID-19 vaccination when pregnant or breastfeeding shows no harm, immunologists weigh in.

Recommended Content:

Women's Health | Coronavirus | COVID-19 Vaccine Efforts | COVID-19 Vaccine Toolkit

DHA IT helps beneficiaries, providers and workforce through pandemic

Article
2/12/2021
Several military personnel, wearing masks, filling out paperwork. One woman is giving the thumbs up sign

DHA IT Teams Deliver Innovative Solutions During Pandemic.

Recommended Content:

Technology | Coronavirus

Printable VAX Fact Can I Get COVID-19 From the Vaccine?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Printable VAX Fact Do I Still Need to Wear a Facemask After I'm Vaccinated?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Printable VAX Fact When can I get the COVID-19 Vaccine?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Printable VAX Fact Who Can Get the Vaccine Now?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Printable VAX Fact Should Children Get the COVID Vaccine?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Printable VAX Fact How Much will the COVID-19 Vaccine Cost?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts

Printable VAX Fact How Many Doses of the Vaccine Will I Get?

Publication
2/12/2021

This is a printable version of the VAX Fact graphic

Recommended Content:

Coronavirus | COVID-19 Vaccine Efforts
<< < ... 6 7 8 9 10  ... > >> 
Showing results 136 - 150 Page 10 of 36

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.